3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
5
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
5
Burkitt Lymphoma
5
Prostatic Neoplasms
2
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
2
Pancreatic Neoplasms
2
Neoplasms
2
Multiple Myeloma
2
Leukemia, Biphenotypic, Acute
2
Hematologic Neoplasms
2
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Thyroid Neoplasms
1
Stomach Neoplasms
1
Rectal Neoplasms
1
Prostate Cancer Recurrent
1
Philadelphia Chromosome
1
Ovarian Neoplasms
1
Neuroblastoma
1
Neoplasm, Residual
1
Myeloproliferative Disorders
1
Melanoma
1
Lymphoma, T-Cell
1
Lymphoma, Non-Hodgkin
1
Lymphoma
1
Lung Neoplasms
1
Leukemia, Myeloid, Chronic-Phase
1
Leukemia, Myeloid, Acute
1
Leukemia
1
Interventions
Specimen Handling
3
Nivolumab
2
Magnetic Resonance Spectroscopy
2
Ipilimumab
2
CTLA-4 Antigen
2
olaparib
1
durvalumab
1
defactinib
1
cediranib
1
capivasertib
1
Restraint, Physical
1
RO5126766
1
Immunoglobulin G
1
Hysterectomy
1
Fluid Therapy
1
Disulfides
1
Biopsy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Carcinoma, Endometrioid
×
Dasatinib
×
90 days
×
Clear all
No trials found.